Pseudomonas aeruginosa virulence factors

Pseudomonas aeruginosa virulence factors encompass a diverse array of molecular mechanisms that enable this opportunistic pathogen to cause severe infections, particularly in immunocompromised patients, by facilitating adhesion, invasion, immune evasion, and tissue damage. Key components include the type III secretion system (T3SS), which injects effectors like ExoS, ExoT, ExoU, and ExoY into host cells to disrupt cytoskeletons and induce apoptosis, as well as exotoxins such as Exotoxin A that inhibit protein synthesis.[1][3][6][7] Other critical factors are quorum sensing for coordinating virulence gene expression, biofilms for antibiotic resistance and persistence, siderophores (pyoverdine and pyochelin) for iron scavenging, and surface structures like flagella and Type IV pili for motility and attachment.[4][6] These factors contribute to high morbidity in nosocomial pneumonia, sepsis, and corneal infections, with T3SS and ExoU strains linked to worse outcomes.[1][2] Antivirulence therapies targeting these—such as T3SS inhibitors or biofilm disruptors—are under development as adjuncts to antibiotics to reduce resistance pressure while allowing immune clearance.[2][4][6] Notably, "Pseudomonas aeruginosa virulence factors" is not a singular therapeutic target like a specific receptor or enzyme but a collective term, complicating precise drug design.[3][6]

Other names

Type III secretion system (T3SS)exotoxins (ExoS, ExoT, ExoU, ExoY, ExoA)quorum sensingbiofilmsflagellaType IV pilisiderophores (pyoverdine, pyochelin)proteases (alkaline protease, elastase A/B, protease IV)pyocyaninalginatePel and Psl exopolysaccharideslipopolysaccharide (LPS)

Disrupting T3SS effector injection, Inhibiting quorum sensing and biofilm formation, Neutralizing secreted toxins, Targeting bacterial surface structures (flagella, LPS), Modulating bacterial metabolism